Page 1101 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1101

2      References


                   35. Zoller T, Junghanss T, Kapaun A, et al. Intravenous artesu-    57. Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med.
                      nate for severe malaria in travelers, Europe. Emerg Infect Dis.   2005;353:924-932.
                      2011;17:771-777.                                    58. Travel-associated dengue infections–United States, 2001-2004.
                   36. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009   MMWR Morb Mortal Wkly Rep. 2005;54:556-558.
                      H1N1 influenza in pregnant and postpartum women in     59. Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clini-
                      California. N Engl J Med. 2010;362:27-35.              cal and laboratory indicators of acute dengue illness. J Infect Dis.
                   37. Louie JK, Gavali S, Acosta M, et al. Children hospitalized with   1997;176:313-321.
                      2009 novel influenza A(H1N1) in California.  Arch  Pediatr     60. Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid
                      Adolesc Med. 2010;164:1023-1031.                       solutions for resuscitation in dengue shock syndrome. N Engl J
                   38. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J.   Med. 2005;353:877-889.
                      Clinical signs and symptoms predicting influenza infection.     61. Ebola: the virus and the disease. Wkly Epidemiol Rec. 1999;74:89.
                      Arch Intern Med. 2000;160:3243-3247.
                                                                          62. Peters  CJ.  Emerging  infections–Ebola  and  other  filoviruses.
                   39. Lyytikainen O, Hoffmann E, Timm H, et al. Influenza A out-  West J Med. 1996;164:36-38.
                      break among adolescents in a ski hostel. Eur J Clin Microbiol
                      Infect Dis. 1998;17:128-130.                        63. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM.
                                                                             Public health assessment of potential biological terrorism
                   40. Martin CM, Kunin CM, Gottlieb LS, Barnes MW, Liu C,   agents. Emerg Infect Dis. 2002;8:225-230.
                      Finland M. Asian influenza A in Boston, 1957-1958. I.
                      Observations in thirty-two influenza-associated fatal cases.     64. Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic
                      AMA. 1959;103:515-531.                                 fevers. Lancet Infect Dis. 2004;4:487-498.
                                                                          65. Bausch DG, Borchert M, Grein T, et al. Risk factors for Marburg
                   41. Martin CM, Kunin CM, Gottlieb LS, Finland M. Asian influ-
                      enza A in Boston, 1957-1958. II. Severe staphylococcal pneu-  hemorrhagic fever, Democratic Republic of the Congo. Emerg
                      monia complicating influenza. AMA. 1959;103:532-542.   Infect Dis. 2003;9:1531-1537.
                   42. Wong SS, Yuen KY. Avian influenza virus infections in humans.     66. Borio L, Inglesby T, Peters CJ, et al. Hemorrhagic fever viruses
                      Chest. 2006;129:156-168.                               as biological weapons: medical and public health management.
                                                                             JAMA. 2002;287:2391-2405.
                   43. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1)
                      infection in humans. N Engl J Med. 2005;353:1374-1385.    67. Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R.
                                                                             Ebola outbreak in Kikwit, Democratic Republic of the Congo:
                   44. Chan PK. Outbreak of avian influenza A(H5N1) virus infec-  discovery and control measures. J Infect Dis. 1999;179(suppl 1):
                      tion in Hong Kong in 1997. Clin Infect Dis. 2002;34(suppl 2):   S259-S262.
                      S58-S64.
                                                                          68. Marburg haemorrhagic fever, Angola.  Wkly Epidemiol Rec.
                   45. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et   2005;80:158-159.
                      al. Human disease from influenza A (H5N1), Thailand, 2004.
                      Emerg Infect Dis. 2005;11:201-209.                  69. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever
                                                                             in Kikwit, Democratic Republic of the Congo: clinical observa-
                   46. Hien TT, Liem NT, Dung NT, et al. Avian influenza A (H5N1)   tions in 103 patients. J Infect Dis. 1999;179(suppl 1):S1-S7.
                      in 10 patients in vietnam. N Engl J Med. 2004;350:1179-1188.
                                                                          70. Emond RT, Evans B, Bowen ET, Lloyd G. A case of Ebola virus
                   47. de Jong MD, Cam BV, Qui PT, et al. Fatal avian influenza A   infection. Br Med J. 1977;2:541-544.
                      (H5N1) in a child presenting with diarrhea followed by coma.
                      N Engl J Med. 2005;352:686-691.                     71. Franz DR, Jahrling PB, McClain DJ, et al. Clinical recognition
                                                                             and management of patients exposed to biological warfare
                   48. de Jong MD, Hien TT. Avian influenza A (H5N1). J Clin Virol.   agents. Clin Lab Med. 2001;21:435-473.
                      2006;35:2-13.
                                                                          72. Guimard Y, Bwaka MA, Colebunders R, et al. Organization of
                   49. Gruber PC, Gomersall CD, Joynt GM. Avian influenza    patient care during the Ebola hemorrhagic fever epidemic in
                      (H5N1): implications for intensive care.  Intensive Care Med.   Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis.
                      2006;32:823-829.                                       1999;179(suppl 1):S268-S273.
                   50. Schultsz C, Dong VC, Chau NV, et al. Avian influenza H5N1     73. Ksiazek TG, Peters CJ, Rollin PE, et al. Identification of a new
                      and healthcare workers. Emerg Infect Dis. 2005;11:1158-1159.
                                                                             North American hantavirus that causes acute pulmonary insuf-
                   51. Sturm-Ramirez KM,  Ellis T, Bousfield B, et al. Reemerging   ficiency. Am J Trop Med Hyg. 1995;52:117-123.
                      H5N1 influenza viruses in Hong Kong in 2002 are highly patho-    74. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary
                      genic to ducks. J Virol. 2004;78:4892-4901.
                                                                             syndrome in the United States: a pathological description of a
                   52. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-  disease caused by a new agent. Hum Pathol. 1995;26:110-120.
                      to-person transmission of avian influenza A (H5N1). N Engl J     75. Peters CJ, Khan AS. Hantavirus pulmonary syndrome: the
                      Med. 2005;352:333-340.
                                                                             new American hemorrhagic fever.  Clin Infect Dis. 2002;34:
                   53. Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continu-  1224-1231.
                      ing global threat. Nat Rev Microbiol. 2010;8:S7-S16.
                                                                          76. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary
                   54. Halstead SB. Dengue. Lancet. 2007;370:1644-1652.      syndrome. Pathogenesis of an emerging infectious disease. Am
                   55. Halstead SB, Suaya JA, Shepard DS. The burden of dengue   J Pathol. 1995;146:552-579.
                      infection. Lancet. 2007;369:1410-1411.              77. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B.
                   56. Simmons CP, Farrar JJ, Nguyen vV, Wills B. Dengue. N Engl J   Humoral immune responses in the hantavirus cardiopulmonary
                      Med. 2012;366:1423-1432.                               syndrome. J Infect Dis. 2000;182:43-48.









            Section05-O-ref.indd   2                                                                                   1/20/2015   4:51:24 PM
   1096   1097   1098   1099   1100   1101   1102   1103   1104   1105   1106